A-Brands

Beiersdorf Acquires Majority Stake In Belgian Life-Science Firm S-Biomedic

By Dayeeta Das
Share this article

Skin care giant Beiersdorf has acquired a majority stake in S-Biomedic NV, a Belgian life-science company involved in skin microbiome research.

In 2018, Beiersdorf invested in S-Biomedic as part of its corporate venture capital activities, and its latest move will further consolidate their collaboration.

S-Biomedic will continue to be managed as a standalone entity under Beiersdorf’s existing microbiome programme and complement the company’s research activities in this field, the Nivea-maker noted.

'An Ideal Strategic Fit'

Dr Gitta Neufang, senior vice president of research and development at Beiersdorf, said, "As skin care experts, research has been at the heart of what we have been doing for 140 years. Therefore, the acquisition of S-Biomedic is an ideal strategic fit to drive our innovation power even further in line with our C.A.R.E.+ strategy.

"Together with the pioneers of S-Biomedic we are taking skincare to the next level and will foster the development of solutions for unmet consumer needs."

Jörn Hendrik Reuter, manager microbiome accelerator at Beiersdorf, added, "We are pleased to welcome S-Biomedic and its dedicated team to the Beiersdorf Group to join forces in this dynamic and highly promising research area.

"The advances of S-Biomedic in biomedical research complement our efforts in this field and open the door to developing products that work in harmony with the natural skin processes."

Microbiome Research And S-Biomedic

In the last few years, microbiome research has gained much attention in science as it offers starting points for skin care innovations.

Founded by Veronika Oudova and Bernhard Paetzold in 2014, S-Biomedic focuses on the balance of the skin’s microbiome and develops active ingredients for cosmetic products by using living skin bacteria.

The microbiome of the skin is a habitat of billions of bacteria and an essential factor for skin health, Beiersdorf added.

Lack of balance in the skin microbiome triggers skin diseases like acne.

Veronika Oudova, CEO of S-Biomedic, said, "Our vision since 2014 when we started S-Biomedic has been to build and promote skin microbiome technologies and make them the new frontier in skin health.

"I am very excited that together with the team we have achieved a very important milestone on that journey. By joining Beiersdorf our novel approach has its path to consumers all over the world."

© 2022 European Supermarket Magazine – your source for the latest A-Brands news. Article by Dayeeta Das. Click subscribe to sign up to ESM: European Supermarket Magazine.

Stay Connected With Our Weekly Newsletter

Processing your request...

Thanks! please check your email to confirm your subscription.

By signing up you are agreeing to our Terms & Conditions and Privacy Policy
Enjoy unlimited digital access for 30 days
Get exclusive access to the latest grocery retail & FMCG news, interviews with industry leading executives, and expert analysis on the trends shaping the sector today
Enjoy unlimited digital access for 30 days
Enjoy unlimited digital access for 30 days
Get exclusive access to the latest grocery retail & FMCG news, interviews with industry leading executives, and expert analysis on the trends shaping the sector today
Enjoy unlimited digital access for 30 days

Copyright © 2023. All rights reserved. Developed by Square1 and powered by PublisherPlus.com